SGMT
Sagimet BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SGMT vs peer average
67/100
SGMT vs. peer average (B vs. C)
Grade spread
B 5 · C 1 · D 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
REPL is the first available peer comparator.
Small-cap clinical biotech with binary trial and financing sensitivity; useful as an event-risk comp, but indication overlap is loose.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SGMT
Sagimet Biosciences
REPL
Replimune Group
Grade
B
D
Momentum
79
99
Value
41
41
Sentiment
63
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs REPL
SGMT / REPL
Grade Position
In line
SGMT vs. peer average (B vs. C)
67/100
Momentum
79
REPLValue
41
SGMTSentiment
63
SGMTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SGMT
REPL is the first peer returned for this comparison set.

